Table 2.
Characteristic | N | Odds ratio (95% CI) | Adjusted odds ratio† (95% CI) |
---|---|---|---|
Age category (years): | 336,794 | ||
< 5 | Ref. | Ref. | |
5–15 | 1.02* (1.01–1.05) | 1.00 (0.98–1.02) | |
> 15 | 0.98* (0.96–0.99) | 1.00 (0.98–1.01) | |
Gender (male) | 327,918 | 1.03*** (1.02–1.05) | 1.00 (0.99–1.02) |
Fever in the previous 2 weeks | 336,456 | 1.05* (1.01–1.10) | 1.36*** (1.30–1.42) |
RDT positive | 331,905 | 1.01 (0.98–1.03) | 1.17*** (1.14–1.20) |
Treatment arm (MDA) | 336,794 | 1.00 (0.98–1.02) | 0.98 (0.70–1.37) |
Heard sensitization messages | 325,856 | 1.20*** (1.17–1.22) | 1.11*** (1.09–1.13) |
MDA = mass drug administration.
* P < 0.05, **P < 0.01, ***P < 0.001.
Random effects for trial cluster and MDA rounds.